Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3435]

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

PSMA PET highlights need for updated prostate cancer therapy guidelines

PSMA PET highlights need for updated prostate cancer therapy guidelines

Countries Pledge € 9 Million for IAEA Cancer Care Initiative

Countries Pledge € 9 Million for IAEA Cancer Care Initiative

Cancer clinical trials bounce back after significant COVID-19 disruption: Data from two large US cancer centers

Cancer clinical trials bounce back after significant COVID-19 disruption: Data from two large US cancer centers

ecancer appoints two new world-renowned trustees, furthering the cause of quality, accessible cancer care across the world

ecancer appoints two new world-renowned trustees, furthering the cause of quality, accessible cancer care across...

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene-edited therapy

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene...

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple myeloma patients

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple...

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

More from ecancer